InsidersTradesSigma
Follow the Scholar Rock Holding Corp. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €7.2bn. The latest transaction was filed on 6 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Mohammed Qatanani. Every trade is free.
Analysts rate Scholar Rock Holding Corp. Strong Buy (bullish), based on 16 analysts. Average price target: US$60.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Scholar Rock Holding Corp. es una empresa biofarmacéutica centrada en el desarrollo de terapias dirigidas para enfermedades graves. La empresa utiliza su plataforma de descubrimiento de fármacos para identificar candidatos terapéuticos innovadores.